Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Modulation of GYS1 expression

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Antisense Drug Against the Human Intercellular Adhesion Molecule 1 (ICAM-1)

ANTIBACTERIAL ANTISENSE AGENTS

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

IDENTIFICATION OF MOLECULAR PATHWAYS AND METHODS OF USE THEREOF FOR TREATING RETINAL NEURODEGENERATION AND OTHER NEURODEGENERATIVE DISORDERS

TARGETING EGLN1 IN CANCER

Angelman syndrome antisense treatment

SPINAL MUSCULAR ATROPHY (SMA) TREATMENT VIA TARGETING OF SMN2 SPLICE SITE INHIBITORY SEQUENCES

Complement component C5 iRNA compositions and methods of use thereof

RNA INTERFERENCE COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS

ANTISENSE OLIGONUCLEOIDES OF GLUTATHIONE S-TRANSFERASES FOR CANCER TREATMENT

Aptamers and use thereof

NOVEL PHOSPHORAMIDITES

MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION

OLIGOMERIC NUCLEIC ACID MOLECULE AND APPLICATION THEREOF

DOUBLE-STRANDED NUCLEIC ACID INHIBITOR MOLECULES CONTAINING A TRILOOP

Compounds and methods for reducing ATXN3 expression

T cells with improved functionality

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF

USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER

Treatment of tumors with miRNA targeting CDK4/CDK6

PROCESS TO INHIBIT OR ELIMINATE EOSINOPHILIC DISEASES OF THE AIRWAY AND RELATED CONDITIONS

METABOLIC BENEFITS OF SHORT MIR-22 MIRNA ANTAGOMIR THERAPIES

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Compositions and their uses directed to huntingtin

ANTISENSE OLIGONUCLEOTIDES TARGETING CARD9

ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF BEST DISEASE

Expression of miRNAs in Placental Tissue

COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

USE OF miRNA 148 CLUSTER AS MARKER FOR DIAGNOSING AND/OR TREATING COGNITIVE IMPAIRMENT-ASSOCIATED DISEASES

L-OLIGONUCLEOTIDE INHIBITORS OF POLYCOMB REPRESSIVE COMPLEX 2 (PRC2)

Methods for preventing graft ischemia reperfusion injury during ex vivo machine perfusion preservation

COMPOSITIONS AND METHODS RELATED TO NUCLEIC ACID ANTICOAGULANTS

NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL8

Saponin Conjugates

RNAI INDUCED REDUCTION OF ATAXIN-3 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 3

OLIGONUCLEOTIDE INHIBITORS OF NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELLS AND THE USES THEREOF

METHODS OF SAFE ADMINISTRATION OF AN IRF5 ANTISENSE OLIGONUCLEOTIDE

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL

Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein

Lipid nanoparticle formulations

Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression

Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors

METHOD FOR REDUCING THE RISK OF A CARDIOVASCULAR EVENT WITH CONJUGATED ANTISENSE COMPOUNDS TARGETING APO(A)

Inhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease

Modulators and modulation of the receptor for advanced glycation end-products RNA

Methods of Manipulating the Fate of Cells

Phosphorothioate-conjugated miRNAs and methods of using the same

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

Multi-Targeting Nucleic Acid Constructs Composed Of Multiple Oligonucleotides That Modulate Gene Expression Through Complimentary Interactions With Targets

Composition for modifying target gene

Methods for treating or preventing ophthalmological conditions

Compositions and therapeutic methods of microRNA gene delivery

OLIGONUCLEOTIDES FOR SNCA MODULATION

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS TARGETING VIRUS GENOMES

COMPOUNDS AND METHODS FOR REDUCING FXI EXPRESSION

Sting-dependent activators for treatment of disease

GENE EDITING BASED CANCER TREATMENT

Dual-acting siRNA based modulation of C9orf72

Compositions and Methods for Immunotherapy

Single-stranded RNA-editing oligonucleotides

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS

Oligonucleotides for PRNP modulation

NR2F6 INHIBITED CHIMERIC ANTIGEN RECEPTOR CELLS

Compositions of Asymmetric Interfering RNA and Uses Thereof

Purification and purity assessment of RNA molecules synthesized with modified nucleosides

HIF 1-alpha antisense oligonucleotides

Inhibition of protein kinases to treat Friedreich ataxia

COMPOSITIONS AND METHODS FOR THE TREATMENT OF COMPLICATIONS AND DISORDERS RELATING TO VON WILLEBRAND FACTOR

Exosomes and miRNA to treat glaucoma

MATRIX METALLOPROTEINASE-1 ANTISENSE OLIGONUCLEOTIDES

TARGETED ELIMINATION OF BACTERIAL GENES

Methods for treating hypercholesterolemia

Oligonucleotides targeting frataxin and related methods

Methods and compositions for modulating lncRNAs and methods of treatment based on lncRNA expression

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Compositions and methods of inhibiting gene expression in a lung

TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Structurally designed shRNAs

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

Bioactive renal cells

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Micro-RNAS and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions

Compositions for Modulating C9ORF72 Expression

PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES

Methods and compositions for inhibiting detoxification response

METHODS FOR DETERMINING THE PRESENCE OR RISK OF DEVELOPING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD)

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

Treating and preventing microbial infections

A GROWTH FACTOR AND EXTRACELLULAR VESICLE FROZEN OR POWDERED ADDITIVE COMPRISING A MESENCHYMAL STEM CELL (MSC) PREPARATION AND METHODS OF USE

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR V

Exon skipping compositions for treating muscular dystrophy

MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD

Treating liver disease by selectively eliminating senescent cells

Treating cardiovascular disease by selectively eliminating senescent cells

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

Methods and compositions related to T-cell activity

FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALING

ANTISENSE COMPOSITION AND METHOD FOR TREATING MUSCLE ATROPHY

SDF-1 Binding Nucleic Acids

COMPOSITIONS AND METHODS FOR DELIVERY OF RNA TO A CELL

Methods for treating triple-negative breast cancer

Chiral design

Selectively altering microbiota for immune modulation

Method of treating and prognosing scoliotic patient subgroups

MUCOSAL HEALING PROMOTER

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

MicroRNA Compounds and Methods for Modulating MIR-122

Compositions and Methods for Treating, Ameliorating, and/or Preventing Viral Infections

Promotion of cardiomyocyte proliferation and regenerative treatment of the heart by inhibition of microRNA-128

Modulation of transthyretin expression

RNA WITH A COMBINATION OF UNMODIFIED AND MODIFIED NUCLEOTIDES FOR PROTEIN EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

Sequence-specific in vivo cell targeting

Methods and compositions for RNA-guided treatment of HIV infection

Methods and compositions for control of arthropod pests

Hippo and dystrophin complex signaling in cardiomyocyte renewal

Oligomers and oligomer conjugates

Interferon production using short RNA duplexes

Nucleic acid simultaneously inhibiting expression of mTOR gene and STAT3 gene

Oligonucleic acid variant libraries and synthesis thereof

Genetic correction of mutated genes

Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof

MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE

RNA preparations comprising purified modified RNA for reprogramming cells

Methods And Compositions For Templated Assembly Of Nucleic Acid Specific Heterocompounds

MLK-regulated microRNAs in angiogenesis and tumor development

METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES

COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN

Treating and preventing microbial infections

Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors

TMPRSS6 iRNA compositions and methods of use thereof

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis

OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72

5′ modified nucleosides and oligomeric compounds prepared therefrom

Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure

MODULATION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE

CTLA-4 aptamer conjugates

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

Methods and compositions for treating cancer using peptide nucleic acid-based agents

Angelman syndrome antisense treatment

Methods for modifying RNA splicing

Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors

METHOD FOR mRNA STABILIZATION

Treatment of HER-2 dependent cancer using an agent that modulates the activity of a miRNA

Multivalent oligonucleotide assemblies

Aptamers for the treatment of sickle cell disease

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Influenza-activated constructs and methods of use thereof

Compositions and their uses directed to huntingtin

RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES

Dynamin 2 inhibitor for the treatment of centronuclear myopathies

Oligonucleotide compounds for targeting huntingtin mRNA

PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS

Methods and compositions for diagnosing and treating diseases

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Preeclampsia

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

ALBUMIN PRODUCTION AND CELL PROLIFERATION

as a diagnostic and therapeutic target for NAFLD, NASH, metabolic syndrome, and hepatic fibrosis

Compositions and Methods for Inhibiting Expression of Transthyretin

Reducing nonsense-mediated MRNA decay

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Single-Stranded RNAI Oligonucleotides Targeting APOC-III

RNA-modulating agents

Oligomers

BIOLOGICAL MATERIALS AND THERAPEUTIC USES THEREOF

EFFICACIOUS MRNA VACCINES

TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY

METHODS FOR DIAGNOSING AND TREATING PROSTATE CANCER

Antisense oligonucleotides for treatment of cancer stem cells

METHODS OF TREATING DIABETES AND/OR PROMOTING SURVIVAL OF PANCREATIC ISLETS AFTER TRANSPLANTATION

USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR V

HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS

Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia

MATERIALS AND METHODS FOR TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 (SCA2) AND OTHER SPINOCEREBELLAR ATAXIA TYPE 2 PROTEIN (ATXN2) GENE RELATED CONDITIONS OR DISORDERS

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

CONDITIONAL PROTEIN TRANSLATION SWITCHES, CONDITIONAL GENE EXPRESSION SYSTEMS AND USES THEREOF

Oligonucleotide analogues incorporating 5-aza-cytosine therein

Methods and compositions for improving exercise endurance, performance, or tolerance

Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability

Compositions and methods for messenger RNA inhibitors

TREATING CANCER WITH CAS ENDONUCLEASE COMPLEXES

RNAi induced reduction of ataxin-3 for the treatment of Spinocerebellar ataxia type 3

Expression control using a regulatable intron

siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

ROLE OF EXOSOMES, EXTRACELLULAR VESICLES, IN THE REGULATION OF METABOLIC HOMEOSTASIS

METHOD OF TREATING KELOIDS OR HYPERTROPHIC SCARS USING ANTISENSE COMPOUNDS TARGETING CONNECTIVE TISSUE GROWTH FACTOR (CTGF)

MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION

Organic compositions to treat EPAS1-related diseases

Nucleic acid molecules and their use in therapy

MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF

Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function

Inhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease

MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS

Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

ENA ANTISENSE OLIGONUCLEOTIDE FOR INHIBITION OF alpha-SYNUCLEIN EXPRESSION

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

COMPOSITION AND METHOD OF USING MIR-302 PRECURSORS AS ANTI-CANCER DRUGS FOR TREATING HUMAN LUNG CANCER

Meta-stable oligonucleotides junctions for delivery of therapeutics

Systems and methods for the treatment of hemoglobinopathies

CRISPR/RNA-guided nuclease systems and methods

RNAs for wound healing

Oncolytic viral vectors and uses thereof

Fidgetin-like 2 as a target to enhance wound healing

COMPOSITIONS AND METHODS FOR TREATING CANCER

Nutlin-3a for treatment of proliferative vitreoretinopathy

Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)

Modulation of angiopoietin-like 3 expression

Methods for the Delivery of Therapeutic Agents to Donor Organs

Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Methods for identification, assessment, prevention, and treatment of cancer using PD-L1 isoforms

Treating and preventing microbial infections

Method of modulating the number and the distribution of tumor-infiltrating leukocytes in tumors

Compositions of asymmetric interfering RNA and uses thereof

DELIVERY OF THERAPEUTIC AGENT

Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules

Compositions of asymmetric interfering RNA and uses thereof

Treatment of tumors with miRNA targeting CDK4/CDK6

Post-selex modification methods

LONG NON-CODING RNA USED FOR ANTICANCER THERAPY

METHOD AND KITS FOR IDENTIFYING OF CDK9 INHIBITORS FOR THE TREATMENT OF CANCER

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Methods to detect motor neuron disease comprising micro-RNAs

Novel Structurally Designed shRNAs

COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer agents

METHODS FOR DOSING AND MONITORING SMAD7 ANTISENSE OLIGONUCLEOTIDE TREATMENT USING BIOMARKER LEVELS

Complement component C5 iRNA compositions and methods of use thereof

TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN

Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue

Oligomers and oligomer conjugates

Exosomes and micro-ribonucleic acids for tissue regeneration

RNA interference for the treatment of gain-of-function disorders

Oligomers

Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS

CRISPR/CAS9-BASED TREATMENTS

Modified L-Nucleic Acid

Methods of treating diabetic nephropathy by administering an anti-vegf-b (vascular endothelial growth factor-b) antibody

METHODS OF INHIBITING CANCER STEM CELLS WITH HMGA1 INHIBITORS

HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

MODIFIED GUIDE RNAS, METHODS AND USES

NTRK2 FUSIONS

K-RAS gene expression-suppressing siRNA, precursor of same, and applications thereof

Isolated mammalian somatic cells containing modified RNA encoding OCT4, SOX2, and KLF4

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

RNAi therapy for treatment and/or prevention of glaucoma

MUCOSAL HEALING PROMOTER

IncRNAS for therapy and diagnosis of angiogenesis

METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND ENHANCING TUMOR VACCINES

High temperature selection of nucleotide-supported carbohydrate vaccines and resulting glycosylated oligonucleotides

Method for assaying MicroRNA, cancer therapeutic agent, and medical composition containing same for cancer therapy

MATERIALS AND METHODS FOR TREATMENT OF DYSTROPHIC EPIDERMOLYSIS BULLOSA (DEB) AND OTHER COLLAGEN TYPE VII ALPHA 1 CHAIN (COL7A1) GENE RELATED CONDITIONS OR DISORDERS

Compositions and methods for inhibiting gene expression of factor XII

COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Oligomeric compounds comprising α-β-constrained nucleic acid

Nucleic acid simultaneously inhibiting expression of mTOR gene and STAT3 gene

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

RNA for treatment or prophylaxis of a liver disease

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Single-stranded RNA-editing oligonucleotides

ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

Piston arrangement

MEANS AND METHODS FOR THE GENERATION OF OLIGODENDROCYTES

Selectively altering microbiota for immune modulation

Method of treating diabetic retinopathy or wet type adult macular degeneration

MIR-320E AND COLORECTAL CANCER

Oligonucleotide compositions with enhanced efficiency

Methods and pharmaceutical compositions for the prophylactic treatment of metastases

NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE

ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING

Method for the diagnosis, prognosis and treatment of cancer metastasis

Process of delivering small RNAs to sperm

Compositions and Methods for Inhibiting Expression of Transthyretin

Recombinant virus products and methods for inhibition of expression of DUX4

Methods of identifying and treating poor-prognosis cancers

Fidgetin-like 2 as a target to enhance wound healing

Methods and compositions for treating cancer using peptide nucleic acid-based agents

MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD

Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression

Cancer Treatment and Immune System Regulation Through FAT10 Pathway Inhibition

CAMK2D antisense oligonucleotides and uses thereof